Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $144.01 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $44.79 | 1 | $0 (2017) |
| iRhythm Technologies, Inc. | $39.20 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $26.82 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $20.99 | 1 | $0 (2017) |
| Amgen Inc. | $12.21 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39.20 | 1 | iRhythm Technologies, Inc. ($39.20) |
| 2019 | $12.51 | 1 | Novartis Pharmaceuticals Corporation ($12.51) |
| 2018 | $14.31 | 1 | Novartis Pharmaceuticals Corporation ($14.31) |
| 2017 | $77.99 | 3 | Actelion Pharmaceuticals US, Inc. ($44.79) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $39.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/06/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $44.79 | General |
| 05/25/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2017 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,064 | 4,074 | $850,018 | $207,423 |
| 2022 | 19 | 1,990 | 4,055 | $871,383 | $211,981 |
| 2021 | 24 | 2,059 | 4,140 | $893,039 | $226,862 |
| 2020 | 25 | 2,578 | 4,530 | $848,828 | $196,487 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 1,068 | $356,712 | $104,566 | 29.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 166 | 173 | $150,031 | $28,741 | 19.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 51 | 53 | $45,237 | $10,389 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 590 | 899 | $63,829 | $10,376 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 143 | $32,032 | $10,301 | 32.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 27 | 142 | $19,596 | $9,306 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $34,103 | $8,344 | 24.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 89 | 250 | $33,000 | $4,653 | 14.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 61 | 173 | $20,414 | $3,741 | 18.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $13,508 | $3,018 | 22.3% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 17 | 131 | $11,266 | $2,609 | 23.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 64 | 621 | $18,630 | $2,592 | 13.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 28 | 78 | $18,018 | $2,079 | 11.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 36 | $7,716 | $1,766 | 22.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 11 | 60 | $5,820 | $1,257 | 21.6% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 17 | 19 | $3,470 | $953.18 | 27.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 17 | 17 | $5,712 | $825.63 | 14.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 28 | 28 | $2,324 | $610.12 | 26.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 34 | 35 | $3,220 | $506.47 | 15.7% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 33 | 34 | $4,080 | $505.76 | 12.4% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 25 | 25 | $1,300 | $284.75 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 559 | 1,147 | $383,098 | $114,755 | 30.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 182 | 207 | $165,728 | $31,286 | 18.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 59 | 61 | $53,220 | $12,264 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 557 | 907 | $64,397 | $10,449 | 16.2% |
About Dr. John Kinch, MD
Dr. John Kinch, MD is a Cardiovascular Disease healthcare provider based in Norwood, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093797425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kinch, MD has received a total of $144.01 in payments from pharmaceutical and medical device companies, with $39.20 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($144.01).
As a Medicare-enrolled provider, Kinch has provided services to 8,691 Medicare beneficiaries, totaling 16,799 services with total Medicare billing of $842,753. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Norwood, MA
- Active Since 11/21/2005
- Last Updated 06/03/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093797425
Products in Payments
- ZIO XT Patch (Device) $39.20
- ENTRESTO (Drug) $26.82
- PRALUENT (Drug) $20.99
- Corlanor (Drug) $12.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Norwood
Gary Mitchell, M.d, M.D
Cardiovascular Disease — Payments: $7,215
Waqar Cheema, Md, MD
Cardiovascular Disease — Payments: $695.99
Nicole Orr, M.d, M.D
Cardiovascular Disease — Payments: $433.17
Dr. Nicholas Ruocco, M.d, M.D
Cardiovascular Disease — Payments: $407.17
Besher Jazmati, M.d, M.D
Cardiovascular Disease — Payments: $206.61
Dr. Kenneth Silverman, M.d, M.D
Cardiovascular Disease — Payments: $84.51